Related Experiment Video

Updated: May 2, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.1K

nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Christine Megerdichian1, Yuliya Olimpiadi2, Sara A Hurvitz1

  • 1University of California, Los Angeles, CA, United States.

Cancer Treatment Reviews
|February 25, 2014
PubMed

Insights

Albumin-bound paclitaxel (nab-paclitaxel) offers improved efficacy and reduced toxicity for breast cancer treatment. This review explores its use with targeted therapies across various stages of breast cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Nanomedicine

Background:

  • Taxanes are crucial chemotherapy agents for breast cancer.
  • Novel formulations like nab-paclitaxel aim to enhance efficacy and reduce toxicity.
  • Nab-paclitaxel is an albumin-bound paclitaxel formulation avoiding solvent-based vehicles.

Purpose of the Study:

  • To review clinical trials of nab-paclitaxel in combination with targeted agents for breast cancer.
  • To evaluate nab-paclitaxel's role in neoadjuvant, adjuvant, and metastatic settings.
  • To discuss efficacy and tolerability of novel breast cancer treatment strategies.

Main Methods:

  • Review of pivotal phase 3 studies and recent phase 2 and 3 clinical trials.
  • Analysis of data on nab-paclitaxel in combination with biologically targeted therapies.
  • Assessment of treatment outcomes in early-stage, advanced, and metastatic breast cancer.

Main Results:

  • Nab-paclitaxel allows higher dosing, shorter infusion times, and no premedication compared to solvent-based paclitaxel.
  • Nab-paclitaxel demonstrated higher response rates and favorable tolerability in breast cancer treatment.
  • Emerging evidence suggests efficacy when nab-paclitaxel is combined with targeted agents.

Conclusions:

  • Nab-paclitaxel represents a significant advancement in breast cancer chemotherapy.
  • Combination therapy with nab-paclitaxel and targeted agents shows promise for improved breast cancer outcomes.
  • Further research is warranted to optimize novel treatment regimens for breast cancer patients.
Keywords:
AdjuvantBevacizumabMetastatic breast cancerNeoadjuvantPaclitaxelTrastuzumabnab-Paclitaxel

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

9.8K
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

22.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K